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Outcome measures in post-stroke 
arm rehabilitation trials: do existing 
measures capture outcomes that 
are important to stroke survivors, 
carers, and clinicians?
Julie Duncan Millar1 , Frederike van Wijck2,  
Alex Pollock1 and Myzoon Ali1
Abstract
Objective: We sought to (1) identify the outcome measures currently used across stroke arm 
rehabilitation randomized trials, (2) identify and compare outcomes important to stroke survivors, carers 
and clinicians and (3) describe where existing research outcome measures capture outcomes that matter 
the most to stroke survivors, carers and clinicians and where there may be discrepancies.
Methods: First, we systematically identified and extracted data on outcome measures used in trials 
within a Cochrane overview of arm rehabilitation interventions. Second, we conducted 16 focus groups 
with stroke survivors, carers and clinicians using nominal group technique, supplemented with eight semi-
structured interviews, to identify these stakeholders’ most important outcomes following post-stroke 
arm impairment. Finally, we described the constructs of each outcome measure and indicated where 
stakeholders’ important outcomes were captured by each measure.
Results: We extracted 144 outcome measures from 243 post-stroke arm rehabilitation trials. The Fugl-
Meyer Assessment Upper Extremity section (used in 79/243 trials; 33%), Action Research Arm Test 
(56/243; 23%), and modified Ashworth Scale (53/243; 22%) were most frequently used. Stroke survivors 
(n = 43), carers (n = 10) and clinicians (n = 58) identified 66 unique, important outcomes related to arm 
impairment following stroke. Between one and three outcomes considered important by the stakeholders 
were captured by the three most commonly used assessments in research.
Conclusion: Post-stroke arm rehabilitation research would benefit from a reduction in the number of 
outcome measures currently used, and better alignment between what is measured and what is important 
to stroke survivors, carers and clinicians.
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Introduction
Up to 77% of stroke survivors experience upper 
limb (arm) impairment,1 which affects function2 and 
reduces health-related quality of life.3 Rehabilitation 
strategies, including those for the arm after stroke, 
should be based on research evidence. However, 
only moderate-quality evidence supports the use of 
interventions to rehabilitate the arm in current clini-
cal practice.4 There is a demand from stroke survi-
vors, carers, clinicians and researchers for research 
into interventions to improve arm function after 
stroke.5,6
Efficacy of interventions should be demonstrated 
using measures that accurately and consistently cap-
ture change following treatment.7 Researchers cur-
rently use a wide range of measures to assess the 
efficacy of arm interventions after stroke within ran-
domized controlled trials; recent work has identified 
at least 48 arm-related measures,8 indicating hetero-
geneity in what is in current use, as well as the wide 
range of possible targets for arm interventions 
including specific impairments, spasticity, pain or 
task-specific function. The measures in current use 
are highly varied in their focus and methods, impact-
ing on researchers’ ability to compare and aggregate 
data from different studies to examine overall effi-
cacy. Consensus on appropriate measures would 
enhance our ability to detect efficacy of interven-
tions through pooled analysis.9 It has been acknowl-
edged that selection of measures for use in trials 
should capture domains of importance to patients, 
carers and clinicians, consider the psychometric 
properties of measures, and feasibility for use in 
clinical and research settings.10,11
There is a need for consensus on measure use 
in post-stroke arm rehabilitation trials.8 The Core 
Outcome Measures in Effectiveness Trials (COMET) 
initiative10,12 provides guidance on development of 
consensus recommendations, highlighting the 
importance of targeting outcomes that are impor-
tant and relevant to patients and clinicians.
Considering the views of stroke survivors, clini-
cians and researchers, the National Institute for 
Neurological Disorders and Stroke-Common Data 
Element13 recommends items for inclusion as part 
of standardized data collection across all stroke 
trials, and the International Consortium for Health 
Outcomes Measurement recommends measures 
for standardized data collection in stroke clinical 
practice.14 Other recommendations exist for gen-
eral stroke outcomes and reflect physicians’ opin-
ions on important outcomes according to the World 
Health Organization International Classification of 
Functioning, Disability and Health framework.15
The Stroke Recovery and Rehabilitation Round 
Table, consisting of researchers and clinicians, has 
generated consensus recommendations for core 
data collection across sensorimotor stroke rehabili-
tation trials, including a recommendation to use the 
Action Research Arm Test for measurement of arm 
activity limitation across trials.16 In addition, work 
has been completed to describe the psychometric 
properties of 53 available arm measures17 in order 
to inform selection. However, due to the wide-
ranging impact of stroke on people’s lives,18 arm-
specific measures are unlikely to capture all 
important outcomes.
To date, there is no clear consensus recommen-
dation for the selection of measures in post-stroke 
arm rehabilitation randomized trials. Furthermore, 
there is a lack of information about which out-
comes are most meaningful to stroke survivors, 
carers and clinicians. With a view to inform recom-
mendations for selecting measures in future trials, 
we sought to investigate (1) existing measures used 
in post-stroke arm rehabilitation research studies, 
(2) outcomes important to stroke survivors, their 
carers and practising clinicians and (3) where 
important outcomes are captured by existing 
measures.
Methods
We conducted a mixed-methods study involving 
three distinct components. First, by means of a sys-
tematic exploration, we identified measures used in 
current post-stroke arm rehabilitation trials. Second, 
we identified outcomes that were important to 
stroke survivors and carers, and clinicians using 
focus groups and interviews. Finally, using system-
atic mapping, we described how well the currently 
used measures captured the outcomes of impor-
tance to stroke survivors, carers and clinicians.
Duncan Millar et al. 739
Outcome measures used in published 
randomized controlled trials
Search strategy and selection criteria. We identified 
all systematic reviews contained within a Cochrane 
overview of systematic reviews for arm rehabilita-
tion after stroke.4 Systematic reviews met the 
inclusion criteria for our exploration if they were 
published, and examined arm rehabilitation in 
adults with stroke. The overview also identified 
reviews that were in progress in February 2014; we 
considered these ‘in progress’ reviews and included 
those that met our criteria and had been published 
by June 2015.
From the eligible systematic reviews, we identi-
fied all included trials. We included randomized 
controlled trials aimed at improving functional 
recovery or reducing arm impairment in adults 
with a clinical diagnosis of stroke. One author 
(J.D.M.) applied these criteria to titles, abstracts 
and, where necessary, full texts. We searched for 
relevant reviews and trials in all languages and 
arranged costless translation where feasible.
Data extraction. Due to the wide-ranging impact of 
arm dysfunction on life following stroke,2,3,18 data 
were extracted on all measures used in post-stroke 
arm rehabilitation trials, rather than only measures 
related to the arm. One author (J.D.M.) extracted 
data on assessment tool characteristics including 
their name, purpose and any modifications. A sec-
ond author (M.A.) independently extracted data 
from a random sample of trials (n = 30) for com-
parison; the authors met to discuss and resolve any 
differences, involving a third author if required, 
although this was not necessary.
We defined a measure as a reproducible ‘scale, 
scoring system, questionnaire or other tool used for 
measuring an outcome’ (p.214).19 Two independent 
authors applied this definition to each assessment 
tool, then agreed on the final list of included out-
come measures through discussion. A third author 
was available if agreement could not be reached; 
however, this was not required. We defined an out-
come as ‘a measurable variable within an outcome 
domain. The outcome can be measured at a variety 
of time points, which must be clearly stated by 
authors of clinical trials’ (p.214).19
Data analysis. We tabulated the frequency of use of 
each measure across all identified trials. We 
reported as separate the instances where the same 
measure was used to capture different outcomes 
(e.g. visual analogue scale could be used to assess 
pain as well as anxiety).
Identification of important outcomes 
according to stroke survivors, carers and 
clinicians
Ethical approval was granted by North West – 
Greater Manchester West Research Ethics Commi-
ttee (15/NW/0939).
Patient and public involvement. An advisory group 
comprising three stroke survivors with arm impair-
ment (two of whom had aphasia), and two carers, 
informed and piloted our methods and participant 
materials.
Design. We undertook focus groups utilizing Nomi-
nal Group Technique. Nominal Group Technique is 
a consensus method that allows participants to 
reflect on, record and express their views in a struc-
tured and equitable way,20 ensuring equal participa-
tion regardless of impairments.21 We supplemented 
the focus group data with semi-structured inter-
views with stroke survivors and carers who were 
unable to attend the focus groups to ensure that we 
captured the views of a wide sample of participants. 
See Figure 1 for an overview of these methods.
Participants. Eligible participants were adult stroke 
survivors with arm impairment, who were able to 
give informed consent and felt able contribute in a 
focus group (for focus group participants), carers 
of stroke survivors with arm impairment, who were 
able to give informed consent, and clinicians with 
experience in working with stroke survivors with 
arm impairment. Carers did not have to attend the 
session with the person that they cared for. Partici-
pants were excluded if they were unable to give 
informed consent.
Research sites and participants were purposively 
sampled to represent urban and rural populations, a 
range of stroke disabilities, ages, times since stroke 
and clinical experience.
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We calculated anticipated recruitment based on 
previous literature22 indicating that data saturation 
could be reached with 10–16 Nominal Group 
Technique focus groups and 5–8 interviews. 
Therefore, we aimed to recruit 136 participants to 
16 focus groups (N = 8 stroke survivor and carer 
focus groups; N = 8 clinicians focus groups) with 
eight participants per group (N = 64 stroke survi-
vors and carers; N = 64 clinicians) and eight inter-
views (N = 8 stroke survivors and/or carers).
Case ascertainment, recruitment and consent. All 
participants were identified face to face or via let-
ter, by local collaborators at eight Scottish health 
board sites. Potential participants for both the focus 
group and interviews expressed interest and were 
then screened and consented for inclusion by one 
author (J.D.M.), a physiotherapist with 10 years’ 
clinical experience with stroke survivors.
Data collection. We conducted Nominal Group 
Technique focus groups with stroke survivors and 
carers, and separately with clinicians. One author 
(J.D.M.) conducted all focus groups with the assis-
tance of two facilitators who also acted as scribes 
or provide assistance for stroke survivors if 
required. Focus groups were held at local sites and 
lasted between 1.5 and 2 hours.
Semi-structured interviews took place with 
stroke survivors, and where appropriate their car-
ers, on stroke rehabilitation wards or in their homes 
for those unable to join groups. For the interview 
group, one author (J.D.M.) conducted all inter-
views following a prespecified schedule to help to 
identify levels of importance for the outcomes 
identified by stroke survivors and carers. Each 
interview lasted between 20 and 80 minutes. All 
sessions were audio recorded and interviews tran-
scribed verbatim.
Stroke survivors were asked: ‘How does your 
arm affect your life after your stroke and what 
matters most to you about this?’ Carers were 
asked: ‘After their stroke, what matters most about 
your family member or friend’s arm that affects 
Figure 1. Overview of methods used for the identification of important outcomes of stroke survivors, carers and 
clinicians.
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your role as a carer?’ Clinicians were asked: 
‘When working with a stroke patient’s arm, which 
outcomes are most important to you?’ Within each 
focus group, participants generated, shared and 
recorded their statements. These statements were 
then discussed and clarified. The top five state-
ments were individually and privately ranked in 
order of importance for each participant according 
to the process set out by Van Breda.23 Summed 
scores were then generated to identify each group’s 
consensus on important statements.23
Data analysis. Data were analysed according to 
methods set out by Van Breda.23 One author 
(J.D.M.) conducted qualitative content analysis 
on the statements identified in the focus groups,24 
coding ‘meaning units’ defined as ‘statements 
that relate to the same central meaning’ (p.106).24 
A second author (M.A., F.V.W. or A.P.) indepen-
dently coded meaning units for each statement 
for comparison and verification. Meaning units 
were then grouped into categories, and categories 
were classed as outcomes. The wording of the 
outcomes was chosen to select a word or phrase 
most closely related to that used by the partici-
pants in statements to demonstrate the nuance of 
the different outcomes. Statements with multiple 
‘meaning units’ and codes were assigned to all 
applicable categories and thus outcomes. Out-
come categories were arranged under themes and 
subthemes. Once the qualitative outcome catego-
ries were agreed, outcome categories were ranked 
considering (1) the number of statements in the 
outcome category, (2) the number of top five 
statements in the outcome category and (3) the 
average sum of statements in the outcome cate-
gory to produce the most popular outcome cate-
gories.23 In order to do this, the following steps 
were undertaken:
1. The average score for each statement was cal-
culated, according to the methods outlined by 
Van Breda.23
2. The generated average sum of scores was used 
to identify the statements with the highest 
average sum of scores to reveal the top five 
statements for each focus group.
3. Statements were considered under their res-
pective outcome category to provide a sum of 
average scores for each outcome category.23
We managed interview data using NVivo. 
Interview transcripts were similarly coded using 
qualitative content analysis. The outcomes identified 
from stroke survivor and carer focus groups and 
interviews were then triangulated; this involved 
cross-checking, comparing and contrasting outcomes 
to identify areas of similarity.25
How well do existing measures capture 
outcomes of importance to stroke 
survivors, carers and clinicians?
Having identified the measures currently used in 
arm rehabilitation trials for stroke and the outcomes 
that were most important to stroke survivors, carers 
and clinicians, we compared and contrasted the data 
to identify whether important outcomes were cap-
tured by the existing measures and where there were 
any discrepancies. To do this, we described the indi-
vidual constructs contained within each measure 
that we identified from trials (e.g. Barthel Index 
comprises toileting, feeding, dressing, grooming 
and mobility). We mapped constituent constructs 
within each trial measure to the outcomes that were 
identified as important by the stroke survivors, car-
ers and clinicians, indicating where an outcome was 
captured, either wholly or in part, by a measure. One 
author (J.D.M.) completed all mapping. Three 
authors (A.P., F.V.W. and M.A.) each second 
reviewed an agreed upon proportion of the meas-
ures. Agreement between authors was >80% on this 
proportion of measures, and any discrepancies were 
discussed to reach consensus. As per the protocol, 
agreement of >80% on the mapping meant that one 
author (J.D.M.) completed the remaining mapping.
Results
Measures used in published randomized 
controlled trials
From 54 systematic reviews included in a Cochrane 
overview, 43 met our inclusion criteria (Figure 2). 
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These systematic reviews contained 736 rand-
omized controlled trials, of which 243 met our 
inclusion criteria (Figure 3). From these 243 trials, 
data were extracted on 188 assessment tools, of 
which 144 met our prespecified definition of a 
measure (Figure 4). Half (72/144) of the measures 
used in existing randomized controlled trials were 
used only once (Supplemental Table 1 contains all 
extracted measures). The 10 most frequently used 
measures are detailed in Table 1.
Identification of outcomes of importance 
to stroke survivors, carers and clinicians
We gained consent from 111 participants. There 
were no drop-outs during data collection. Partici-
pants included 43 stroke survivor participants (16 
women and 19 men in focus group; 3 women and 5 
men in interview) 10 carer participants (5 women 
and 3 men in focus group; 1 women and 1 man in 
interview). See Table 2 for stroke survivor and carer 
demographics.
There were 58 clinician participants (median 
years’ experience in stroke rehabilitation 13.5, 
interquartile range (7.0, 19.8)). The clinicians’ 
group included 23 physiotherapists, 15 occupa-
tional therapists, 7 nurses, 5 support workers, 4 
consultants, 1 Allied Health Professional consult-
ant, 1 speech and language therapist, 1 clinical neu-
ropsychologist and 1 orthotist.
We had planned to recruit 136 participants, but 
did not meet this target. Nevertheless, we achieved 
data saturation after 14 focus groups and 6 inter-
views; saturation was defined as attainment of no 
more new outcomes identified with each subse-
quent focus group or interview. All collected data 
were used in the analysis.
Stroke survivor and carer focus groups identi-
fied 43 important outcomes, and clinicians identi-
fied 32 important outcomes; of these, 9 outcomes 
were shared between both groups. Therefore, 66 
unique, important outcomes relating to living 
with arm impairment after stroke were identified 
(see Supplemental Table 2 for all outcomes and 
illustrative participant quotes and Supplemental 
Tables 3(a) and (b) for themes and subthemes for 
stroke survivor and carer, and clinician focus 
group outcomes).
Stroke survivors identified the outcomes of 
‘Independence, freedom and autonomy’, ‘Difficulty 
(with routine tasks)’ and ‘Everyday tasks’ as their 
three most important outcomes (Figure 5).
For the outcome ‘Independence, freedom & 
autonomy’ stroke survivors spoke about the impact 
of arm dysfunction on their independence, of want-
ing the freedom to do what they wanted to do, 
when they wanted to do it. This was demonstrated 
with the quote:
Figure 2. Inclusion of systematic reviews identified 
from overview.4
Figure 3. Inclusion of studies identified within 
systematic reviews.
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My independence has been stripped away from me 
because I can’t drive. (Focus group, stroke survivor)
For stroke survivors, here independence is not 
necessarily related to doing something unaided or 
independently (which was identified in other out-
comes), as may be described by clinicians but 
instead about the loss of freedom and independ-
ence. As well as being distinct from level of inde-
pendence, ‘Independence, freedom and autonomy’ 
was separate from ‘Reliance on others’, which 
focused more on the dependence on another per-
son being more of an issue than the loss of 
independence:
Figure 4. Inclusion of measures from list of assessment tools extracted from studies.
Table 1. Ten most frequently used measures in stroke arm rehabilitation trials.
Rank Research measure Number of uses 
across 243 trials (%)
Number of times original 
measure was modified* (%)
First Fugl-Meyer Assessment Upper Extremity section 79 (33) 12/79 (15)
Second Action Research Arm Test 56 (23) 1/56 (2)
Third Modified Ashworth Scale 53 (22) 0/53
Fourth Motor Activity Log 43(18) 7/43 (16)
Fifth Functional Independence Measure 35 (14) 11/35 (31)
Sixth Goniometer to assess range of movement 32 (13) 4/32 (13)
Seventh Wolf Motor Function test 29 (12) 5/29 (17)
Eighth= Barthel Index 28 (11.5) 1/28 (4)
Eighth= Dynamometry to assess strength 28 (11.5) 0/28
Tenth Visual Analogue Scale for pain 24 (10) 5/24 (21)
Note: = denotes measure ranked as having equal frequency of use, as another measure *modifications are defined as researcher 
amending original measure by, for example, excluding or changing items in the measure. Formal published modified measures (e.g. 
modified Ashworth Scale) are described separately.
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I have to rely on my partner to do everything. (Focus 
group, carer)
‘Difficulty (with routine tasks)’ was illustrated by 
quotes such as,
Every ordinary action you once did without thinking 
about was impossible at first and is now very difficult 
and slow. (Focus group, stroke survivor)
Here, the focus was on general difficulties 
resulting from stroke rather than the task itself. 
‘Everyday tasks’ evidenced the wide-ranging 
impact of upper limb problems on general everyday 
tasks rather than specific activities of daily living, 
as described by one carer,
I have to do more tasks for my partner. e.g. opening 
bottle tops, and help her find other ways, but we do it 
together. (Focus group, carer)
Stroke survivors and carers did describe the 
importance of specific daily tasks in separate state-
ments (e.g. personal care and meal time); these 
were ranked lower and are reported separately 
(Supplemental Table 2).
Clinicians identified ‘Everyday tasks’ and 
‘Pain’ equally as their most important outcomes 
(Figure 5). Similar to the stroke survivors and car-
ers, clinicians more frequently spoke about the 
broad impact of upper limb function on daily life 
in ‘Everyday tasks’ with one clinician reporting 
that it was important to ‘Increase functional use of 
Table 2. Stroke survivor and carer demographics for focus groups and interviews.
All focus group and interview 
participants demographics
Stroke survivors (n = 43) Carers (n = 10)
Women (%) 19 (44.2) 6 (60)
Median age (range) 60 years [IQR: 55, 67] (39–89 years) 63.5 years [IQR: 57.8, 71.5] (34–
78 years)
Median modified Rankin Scale (range) 2 [IQR: 2, 3] (1–5) n/a
Median time post stroke (range) 1.3 years, IQR [0.6, 3.0] (4 days to 
11 years)
n/a
Live alone (%) 11 (25.6) n/a
Self reported that speech was affected 
by stroke (%)
21 (48.8) n/a
Self reported that mood was affected 
by stroke (%)
30 (69.8) n/a
IQR: interquartile range; n/a: not applicable.
Figure 5. The 10 most important outcomes for stroke survivors, carers and clinicians and the rank of the outcomes.
Note: = denotes outcome ranked equally important as another outcome. Outcomes ranked 1 were the most important.
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upper limb in everyday tasks’ rather than focus-
sing on the specific tasks. Clinicians described the 
importance of ‘No pain or manageable pain’. 
Shared priorities across both groups included 
‘Everyday tasks’, ‘Pain’ and ‘Muscle tone & spas-
ticity’ (Figure 6). Clinicians mentioned specific 
outcomes that were identified by stroke survivors, 
including driving, working and hobbies. However, 
they instead described these outcomes as part of 
the overall picture in a wider context such as eve-
ryday tasks, life and leisure or overall function.
The triangulation of interview and focus group 
outcomes and statements revealed similarity in 
35/43 focus group outcomes supported by state-
ments in the interview data. Interviews identified 
four categories that were discussed but not ranked in 
focus group data and thus did not form outcomes: 
‘Attitudes of others’, ‘Need’, ‘In bed’ and ‘Prognosis’ 
and one category that was not discussed at all in 
focus groups: ‘Anticipating difficulties at home’.
How well do existing measures capture 
outcomes of importance to stroke 
survivors, carers and clinicians?
We mapped the 144 measures used in clinical trials 
to the 66 most important unique outcomes identi-
fied by stroke survivors, carers and clinicians. 
Supplemental Table 4 describes which of the 10 
most important outcomes from stroke survivors, 
carers and clinicians (generated from the stroke sur-
vivor and carer, and clinician focus group state-
ments) were captured by the 10 most frequently 
used measures in trials.
One outcome (Everyday tasks) was ranked in the 
top 10 by both stroke survivors and carers, and cli-
nicians. Thus combining the top 10 outcomes from 
both stroke survivors and carers, and clinicians gen-
erated 19 unique, most important outcomes.
The stroke survivors and carers’ most important 
outcome of ‘Independence, freedom and autonomy’ 
was not captured by any of the 10 most frequently 
used measures. The clinicians’ most important out-
come of ‘Everyday tasks’, which included activities 
of daily living, was not captured by any of the three 
most frequently used measures.
Only three measures (Assessment of Quality of 
Life Scale, Stroke Impact Scale version 2.0 and 
Stroke Impact Scale version 3.0) captured stroke 
survivors and carers’ most important outcome of 
‘Independence, freedom & autonomy’, but these 
were not commonly used in clinical trials being 
used in 1/243, 12/243 and 6/243 trials, respectively. 
The three most frequently used measures in trials 
(Fugl-Meyer Assessment Upper Extremity section, 
Action Research Arm Test and modified Ashworth 
Figure 6. The nine outcomes identified by both stroke survivors and carers, and clinicians, and the rank of 
importance of these shared outcomes for each group.
Note: = denotes the outcome ranked equally important as another outcome. Ranking started at 1 for the most important out-
come down to 43 (lower importance) for stroke survivors and carers, and down to 32 (lower importance) for clinicians.
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Scale) only captured between one and three impor-
tant outcomes in the top 10 of both stroke survivor 
and carers, and clinicians (‘Pain’, ‘Difficulty’, 
‘Tone and spasticity’, and ‘Arm care, positioning, 
and hygiene’). Of the 10 most frequently used out-
come measures, the Barthel Index captured the 
highest number of important outcomes in each of 
the stroke survivors and carers, and clinicians top 
10 lists, and was ranked eighth equal in frequency 
of use in randomized trials.
Discussion
We sought to identify measures currently used 
across stroke arm rehabilitation randomized trials 
and found 144 measures in current use across 243 
trials. We also aimed to identify and compare 
outcomes important to stroke survivors and car-
ers, and clinicians and describe where existing 
research measures capture outcomes that matter 
most to stroke survivors, carers and clinicians 
and where there may be discrepancies. Our 
results indicate that, despite some overlap, stroke 
survivors and carers tend to prioritize different 
outcomes when compared with clinicians. 
Despite a wide range of measures in current use 
across randomized trials, those most frequently 
used do not adequately capture the outcomes that 
are considered most important by stroke survi-
vors, carers and clinicians.
Consistent with previous work,8 we observed 
heterogeneity in research measure use: the most 
frequently used research measure (Fugl-Meyer 
Assessment Upper Extremity section) was used in 
only one-third of trials and 50% of measures were 
used only once. Even the single construct of pain 
was assessed using 21 different measures. 
Furthermore, 21/188 (11%) of identified assess-
ment tools were poorly described and therefore 
not reproducible, and even well-described meas-
ures were modified, for example, researchers 
changed the Fugl-Meyer Assessment Upper 
Extremity section on 12/79 (15%) occasions. 
Heterogeneity and inconsistencies in arm out-
come assessment limit the ability to pool data in a 
meaningful way and synthesize evidence of the 
efficacy of post-stroke arm interventions to 
inform guidelines and clinical practice. Therefore, 
this uncoordinated measurement of outcomes 
undermines the evidence base for clinical practice. 
Targeted selection from a narrower collection of 
measures for use across stroke arm rehabilitation 
randomized trials would facilitate the generation of 
high-quality data for efficacy analyses. This selec-
tion should capture outcomes that are relevant to 
stroke survivors, carers and clinicians.10,11
We identified stroke survivors and carers, and 
clinicians’ outcomes of importance related to liv-
ing with arm dysfunction after stroke. Important 
outcomes generally differed between stroke survi-
vors and carers on one hand, and clinicians on the 
other hand. Our results show that stroke survivors 
identified specific things that matter to them, and 
clinicians generally identified outcomes in a wider 
context. This is not surprising, given that the 
questions posed to participants were designed to 
identify their own priorities and we anticipated het-
erogeneity in outcomes. Furthermore, we expected 
a difference in the wording and terminology used 
between stroke survivors and carers, and clinicians 
plus reported outcomes to reflect nuance of the 
wording. Perhaps surprisingly, a lot of the out-
comes identified by stroke survivors who were 
in-patients on rehabilitation wards in their acute/
subacute phase (<six months post stroke) were 
similar to those identified by those who were in the 
home and in the chronic phase (⩾six months post 
stroke). This means that the outcomes identified in 
focus groups would in part reflect those that matter 
to stroke survivors across the post-stroke phases. 
However, researchers and clinicians may wish to 
consider the outcomes identified in the interviews 
by those at home or in the ward to explore out-
comes that may be more relevant to different 
groups of stroke survivors. For example, 
‘Prognosis’ and ‘Anticipating difficulties at home’ 
may be considered more important for in-patients.
We found few shared outcomes between stroke 
survivors and carers, and clinicians and consider-
able variations in ranking of any shared outcomes 
(e.g. pain was ranked #1 for clinicians and #12 for 
stroke survivors and carers). This disparity could 
have implications for person-centred care,26 since 
stroke survivors and carers, and clinicians may be 
approaching post-stroke arm rehabilitation with 
differing expectations and goals. Nevertheless, 
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clinicians acknowledged the need to prioritize 
person-centred outcomes (ranked 5/32) and goal 
attainment (ranked 6/32). The difference in out-
comes and rankings could be an indication of the 
different approaches to rehabilitation; stroke sur-
vivors and carers may focus on their long-term 
life goal, while clinicians may focus more on 
short and intermediate goals or different out-
comes to enable long-term goal attainment. 
Clinicians consider a range of outcomes relevant 
to post-stroke arm rehabilitation such as ‘Pain’ 
‘Everyday tasks’ and ‘Tone and spasticity’ that 
were also frequently captured in trials. However, 
clinicians also identified outcomes such as 
‘Acceptance’, ‘Expectation’, ‘Coping and self-
management’ and ‘Knowledge and understand-
ing’; these highlight the complexity of arm 
intervention delivery in clinical practice. Yet, our 
findings show that these outcomes are not fre-
quently captured in research. Research outcome 
measures that addressed clinician priorities, such 
as person-centred outcomes and goal attainment, 
were not frequently used in randomized trials. For 
example, Goal Attainment Scaling and the 
Canadian Occupational Performance Measure 
were used in 4/243 and 1/243 trials, respectively.
In future randomized trials, there is scope to 
capture a greater number of important outcomes by 
carefully selecting complementary primary, sec-
ondary and tertiary outcome measures from a 
smaller pool of available measures. As well as cap-
turing important outcomes, the selected research 
outcome measures must consider the aims of the 
trial, potentially including whether the intervention 
aims to target restitution of pre-stroke behaviour or 
compensation with a new behaviour. It is clear that 
work is needed to improve capture of the outcomes 
that are important to stroke survivors, carers and 
clinicians, while ensuring that researchers select 
from a smaller pool of outcome measures to 
enhance comparability.
We build on previous work8,12–17 to provide a 
comprehensive picture of outcome measure use 
across arm rehabilitation randomized trials in 
stroke. We did not restrict our study to only those 
outcome measures that captured arm impairment, 
but included the full range of measures used in arm 
rehabilitation trials following stroke. Similarly, we 
asked stroke survivors and carers to prioritize what 
matters most to them in terms of life with arm 
problems due to stroke, rather than the aspects of 
arm recovery that were most important to them. 
Outcomes from stroke survivors and carers, and 
clinicians extended beyond the arm as a body 
structure and identified how arm impairment 
relates to other areas of the lived experience, 
including problems with frustration, quality of life, 
and independence. This is consistent with recent 
work exploring experiences of upper limb dysfunc-
tion following stroke.18 Our study provides a wider 
picture of the overall impact of arm impairment on 
life after stroke and describes the extent to which 
important outcomes are captured across current tri-
als. Furthermore, our study provides evidence on 
the importance of looking beyond utilizing only 
arm-specific measures in upper limb rehabilitation 
trials in stroke.
Our study has some limitations. We identified 
randomized trials based on a Cochrane overview 
rather than undertaking a new systematic review. 
However, the rigour of the original Cochrane 
overview4 permitted the systematic and compre-
hensive identification of trials in this area; we also 
supplemented these data by contacting the authors 
of reviews that were on-going at the time of publi-
cation to identify recent reviews and randomized 
trials. Furthermore, we generated data on important 
outcomes based on participants sampled from 
Scotland only. So it is possible that different group 
compositions may have produced different out-
comes and ranking. However, we sought to mitigate 
potential bias by purposively sampling to obtain a 
range of stroke survivor participants with different 
levels of impairment and chronicity, clinicians with 
different experience and expertise, as well as urban 
and rural locations across the country.
We took steps to ensure trustworthiness in the 
collection, analysis and reporting of the qualita-
tive data. This included: use of a reflexive jour-
nal to critically reflect on the researchers’ 
position, interactions, emerging themes and out-
comes and any points of note that may affect the 
understanding of the data; de-briefs following 
focus groups; member checking of analysis of 
focus group statements to avoid bias and enhance 
dependability and credibility; triangulation of 
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data using multiple sources (focus group and 
interview); and detailed description of methods 
and reporting of outcomes and statements to 
ensure transparency and dependability.
The results of our study have implications for 
clinical practice and future research. Clinicians and 
researchers may wish to consider the outcomes of 
importance identified in this study when working 
with stroke survivors with arm dysfunction and 
their carers.
Clinical messages
•• The outcomes that were important to stroke 
survivors and carers differed from those 
identified by clinicians. Stroke survivors 
and carers identified specific things that 
matter to them, and clinicians generally 
identified outcomes in a wider context.
•• Current post-stroke arm rehabilitation tri-
als do not fully capture the outcomes that 
are important to stroke survivors, carers 
and clinicians.
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